"Brilliant Tomorrow" has a group of ophthalmologists represented by Professor Li Zhisheng. "Glory Tomorrow" has an international invention patent, that is, a medical instrument with independent intellectual property rights-computer automatic frequency modulation laser amblyopia therapeutic apparatus. With the comprehensive treatment of the system, the curative effect is far ahead in the world. Brilliant tomorrow will develop in a professional, large-scale and scientific way, and become a leader in promoting children's ophthalmology medical care in China. Brilliant Tomorrow pursues the harmonious unity of social responsibility and self-development, and actively participates in social charity. Guang Cai is currently the national designated hospital for children with amblyopia of China Children's and Teenagers' Fund tomorrow. The Ministry of Civil Affairs of China plans to provide free general survey, free hospitalization and treatment for children with amblyopia in poverty-stricken areas in the national designated hospital tomorrow and the designated hospital of Sir John Hong Kong Children's Amblyopia Fund in China. Over the past five years, we have set foot in more than 80 poverty-stricken areas and counties in China, and successfully cured 1367 poor children with amblyopia, which has been commended by the Ministry of Civil Affairs and UNICEF China for many times and won favorable comments from all walks of life.

Glory tomorrow will make every amblyopic child have a pair of loving, healthy and bright eyes, no matter how much wealth.

Guang Cai will grow healthily and rapidly tomorrow, and the competitiveness of brand core technologies will continue to improve. With tomorrow's national service network, strict medical management and strong professional team in Guang Cai, we are striving to build a world-class medical brand.